Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 60 articles:
HTML format
Text format



Single Articles


    June 2018
  1. BERGENGREN L, Kaliff M, L Larsson G, Karlsson MG, et al
    Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12538.
    PubMed     Text format     Abstract available


    May 2018
  2. DRISCOLL SD, Tappen RM, Newman D, Voege-Harvey K, et al
    Accuracy of visual inspection performed by community health workers in cervical cancer screening.
    Int J Gynaecol Obstet. 2018 May 22. doi: 10.1002/ijgo.12535.
    PubMed     Text format     Abstract available


    January 2018
  3. MAGED AM, Saad H, Salah E, Meshaal H, et al
    Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening.
    Int J Gynaecol Obstet. 2018 Jan 31. doi: 10.1002/ijgo.12453.
    PubMed     Text format     Abstract available


    December 2017
  4. HUCHKO MJ, Ibrahim S, Blat C, Cohen CR, et al
    Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
    Int J Gynaecol Obstet. 2017 Dec 2. doi: 10.1002/ijgo.12415.
    PubMed     Text format     Abstract available


    August 2017
  5. ZHANG X, Ding J, Tao X, Qian H, et al
    Diagnosis and treatment of cervical papillary squamous cell carcinoma with unknown depth of stromal invasion.
    Int J Gynaecol Obstet. 2017;138:190-193.
    PubMed     Text format     Abstract available


    July 2017
  6. MABUCHI S, Kozasa K, Kimura T
    Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer.
    Int J Gynaecol Obstet. 2017 Jul 28. doi: 10.1002/ijgo.12284.
    PubMed     Text format     Abstract available


  7. OGILVIE G, Nakisige C, Huh WK, Mehrotra R, et al
    Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:15-19.
    PubMed     Text format     Abstract available


  8. WHITE HL, Meglioli A, Chowdhury R, Nuccio O, et al
    Integrating cervical cancer screening and preventive treatment with family planning and HIV-related services.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:41-46.
    PubMed     Text format     Abstract available


  9. BASU P, Meheus F, Chami Y, Hariprasad R, et al
    Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:26-32.
    PubMed     Text format     Abstract available


  10. TSU VD
    Cervical cancer prevention for all women: Why now?
    Int J Gynaecol Obstet. 2017;138 Suppl 1:1-3.
    PubMed     Text format    


  11. CAMPOS NG, Sharma M, Clark A, Lee K, et al
    The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:47-56.
    PubMed     Text format     Abstract available


  12. WITTET S, Aylward J, Cowal S, Drope J, et al
    Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:57-62.
    PubMed     Text format     Abstract available


  13. HOLME F, Kapambwe S, Nessa A, Basu P, et al
    Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:63-68.
    PubMed     Text format     Abstract available


  14. DRUMMOND JL, Were MC, Arrossi S, Wools-Kaloustian K, et al
    Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:33-40.
    PubMed     Text format     Abstract available


  15. TSU VD, Ginsburg O
    The investment case for cervical cancer elimination.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:69-73.
    PubMed     Text format     Abstract available


  16. ARANDA S, Berkley S, Cowal S, Dybul M, et al
    Ending cervical cancer: A call to action.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:4-6.
    PubMed     Text format     Abstract available


  17. CASTLE PE, Murokora D, Perez C, Alvarez M, et al
    Treatment of cervical intraepithelial lesions.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:20-25.
    PubMed     Text format     Abstract available


  18. LAMONTAGNE DS, Bloem PJN, Brotherton JML, Gallagher KE, et al
    Progress in HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:7-14.
    PubMed     Text format     Abstract available


    June 2017
  19. PISTA A, de Oliveira CF, Lopes C, Cunha MJ, et al
    Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Int J Gynaecol Obstet. 2017 Jun 20. doi: 10.1002/ijgo.12243.
    PubMed     Text format     Abstract available


  20. LASKOW B, Figueroa R, Alfaro KM, Scarinci IC, et al
    A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Int J Gynaecol Obstet. 2017 Jun 7. doi: 10.1002/ijgo.12204.
    PubMed     Text format     Abstract available


  21. CHIGBU CO, Onyebuchi AK, Onyeka TC, Odugu BU, et al
    The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria.
    Int J Gynaecol Obstet. 2017;137:319-324.
    PubMed     Text format     Abstract available


    May 2017
  22. HAN Y, Li N, Zhang R, Li X, et al
    Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma.
    Int J Gynaecol Obstet. 2017;137:150-156.
    PubMed     Text format     Abstract available


    April 2017
  23. KONERU A, Jolly PE, Blakemore S, McCree R, et al
    Acceptance of peer navigators to reduce barriers to cervical cancer screening and treatment among women with HIV infection in Tanzania.
    Int J Gynaecol Obstet. 2017 Apr 8. doi: 10.1002/ijgo.12174.
    PubMed     Text format     Abstract available


    February 2017
  24. PATEL H, Pcolkina K, Strazdina K, Viberga I, et al
    Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12117.
    PubMed     Text format     Abstract available


  25. GONZALEZ-BOSQUET E, Fernandez S, Sabra S, Lailla JM, et al
    Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.
    Int J Gynaecol Obstet. 2017;136:229-231.
    PubMed     Text format     Abstract available


  26. VODICKA EL, Babigumira JB, Mann MR, Kosgei RJ, et al
    Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
    Int J Gynaecol Obstet. 2017;136:220-228.
    PubMed     Text format     Abstract available


    January 2017
  27. GIANNELLA L, Fodero C, Boselli F, Rubino T, et al
    Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2017 Jan 27. doi: 10.1002/ijgo.12106.
    PubMed     Text format     Abstract available


  28. FIGUEROA-DOWNING D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, et al
    Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil.
    Int J Gynaecol Obstet. 2017;136:33-39.
    PubMed     Text format     Abstract available


  29. ZHANG G, Lang J, Shen K, Zhu L, et al
    High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.
    Int J Gynaecol Obstet. 2017;136:47-52.
    PubMed     Text format     Abstract available


  30. FAJARDO-RAMIREZ OR, Barboza-Cerda MC, Ortiz-Lopez R, Rojas-Martinez A, et al
    Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.
    Int J Gynaecol Obstet. 2017;136:40-46.
    PubMed     Text format     Abstract available


    December 2016
  31. MARIANI L, Preti M, Cristoforoni P, Stigliano CM, et al
    Overview of the benefits and potential issues of the nonavalent HPV vaccine.
    Int J Gynaecol Obstet. 2016 Dec 7. doi: 10.1002/ijgo.12075.
    PubMed     Text format     Abstract available


    November 2016
  32. COMPARETTO C, Epifani C, Manca MC, Lachheb A, et al
    Uptake of cervical cancer screening among the migrant population of Prato Province, Italy.
    Int J Gynaecol Obstet. 2016 Nov 25. doi: 10.1002/ijgo.12067.
    PubMed     Text format     Abstract available


  33. MARIANI L, Igidbashian S, Sandri MT, Vici P, et al
    The clinical implementation of primary HPV screening.
    Int J Gynaecol Obstet. 2016 Nov 21. doi: 10.1002/ijgo.12065.
    PubMed     Text format     Abstract available


    July 2016
  34. FREY MK, Roselli N, Gertz E, Cuc JC, et al
    Cervical cancer screening in Santiago Atitlan, Guatemala.
    Int J Gynaecol Obstet. 2016 Jul 2. pii: S0020-7292(16)30216.
    PubMed     Text format    


  35. MIYAMOTO S, Hasegawa J, Morioka M, Hirota Y, et al
    The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2.
    Int J Gynaecol Obstet. 2016;134:45-8.
    PubMed     Text format     Abstract available


  36. NEGULESCU RA, Catarino R, De Vuyst H, Undurraga-Malinverno M, et al
    Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers.
    Int J Gynaecol Obstet. 2016;134:107-13.
    PubMed     Text format     Abstract available


  37. BOONLIKIT S
    Performance of the abbreviated Reid colposcopic index in prediction of high-grade lesions.
    Int J Gynaecol Obstet. 2016;134:41-4.
    PubMed     Text format     Abstract available


    June 2016
  38. NAUD PS, Muwonge R, Passos EP, Magno V, et al
    Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil.
    Int J Gynaecol Obstet. 2016;133:351-4.
    PubMed     Text format     Abstract available


    May 2016
  39. OLSON B, Gribble B, Dias J, Curryer C, et al
    Cervical cancer screening programs and guidelines in low- and middle-income countries.
    Int J Gynaecol Obstet. 2016 May 26. pii: S0020-7292(16)30155.
    PubMed     Text format     Abstract available


    March 2016
  40. RANJIT A, Gupta S, Shrestha R, Kushner AL, et al
    Awareness and prevalence of cervical cancer screening among women in Nepal.
    Int J Gynaecol Obstet. 2016 Mar 24. pii: S0020-7292(16)30044.
    PubMed     Text format     Abstract available


  41. SANTESSO N, Mustafa RA, Wiercioch W, Kehar R, et al
    Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2016;132:266-71.
    PubMed     Text format     Abstract available


    February 2016
  42. MOEIN S, Mohajer R
    Fluorescein sodium as a contrast agent for colposcopy.
    Int J Gynaecol Obstet. 2016;132:238-9.
    PubMed     Text format    


    December 2015
  43. COLTURATO LF, Signorini Filho RC, Fernandes RC, Gebrim LH, et al
    Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence.
    Int J Gynaecol Obstet. 2015 Dec 19. pii: S0020-7292(15)00733.
    PubMed     Text format     Abstract available


  44. SANTESSO N, Mustafa RA, Schunemann HJ, Arbyn M, et al
    World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.
    Int J Gynaecol Obstet. 2015 Dec 14. pii: S0020-7292(15)00716.
    PubMed     Text format     Abstract available


    November 2015
  45. MUSTAFA RA, Santesso N, Khatib R, Mustafa AA, et al
    Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy.
    Int J Gynaecol Obstet. 2015 Nov 12. pii: S0020-7292(15)00663.
    PubMed     Text format     Abstract available


    October 2015
  46. SHRIVASTAVA SK, Mahantshetty U, Narayan K
    Principles of radiation therapy in low-resource and well-developed settings, with particular reference to cervical cancer.
    Int J Gynaecol Obstet. 2015;131 Suppl 2:S153-8.
    PubMed     Text format    


  47. SANKARANARAYANAN R
    HPV vaccination: The most pragmatic cervical cancer primary prevention strategy.
    Int J Gynaecol Obstet. 2015;131 Suppl 1:S33-5.
    PubMed     Text format     Abstract available


  48. SEOUD M, Lundqvist EA, Fujiwara K
    Targeted therapy in gynecologic cancers: Ready for prime time?
    Int J Gynaecol Obstet. 2015;131 Suppl 2:S150-2.
    PubMed     Text format    


    September 2015
  49. SELMOUNI F, Sauvaget C, Belakhel L, Lucas E, et al
    Organization and evaluation of a pilot cervical cancer screening program in Morocco.
    Int J Gynaecol Obstet. 2015 Sep 25. pii: S0020-7292(15)00594.
    PubMed     Text format     Abstract available


  50. CAI J, Yang L, Dong W, Wang H, et al
    Retrospective comparison of laparoscopic versus open radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer.
    Int J Gynaecol Obstet. 2015 Sep 25. pii: S0020-7292(15)00591.
    PubMed     Text format     Abstract available


    August 2015
  51. KAWAGUCHI R, Tanase Y, Haruta S, Yoshida S, et al
    Addition of aprepitant to standard therapy for prevention of nausea and vomiting among patients with cervical cancer undergoing concurrent chemoradiotherapy.
    Int J Gynaecol Obstet. 2015 Aug 19. pii: S0020-7292(15)00494.
    PubMed     Text format    


  52. LIU Z, Li X, Li W, Yang Y, et al
    Robotic nerve-sparing radical hysterectomy for locally advanced cervical cancer after neoadjuvant chemotherapy.
    Int J Gynaecol Obstet. 2015 Aug 4. pii: S0020-7292(15)00454.
    PubMed     Text format     Abstract available


    July 2015
  53. XAVIER-JUNIOR JC, Vale DB, Vieira LF, Lima MT, et al
    Results of screening for cervical cancer among pregnant and non-pregnant women in Brazil.
    Int J Gynaecol Obstet. 2015;130:36-9.
    PubMed     Text format     Abstract available


  54. LI X, Yang R, Jia Y, Zhou J, et al
    Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
    Int J Gynaecol Obstet. 2015;130:31-5.
    PubMed     Text format     Abstract available


    June 2015
  55. YI X, Ding J, Zhang Y, Liu X, et al
    Laparoscopic radical trachelectomy followed by chemotherapy in a pregnant patient with invasive cervical cancer.
    Int J Gynaecol Obstet. 2015 Jun 23. pii: S0020-7292(15)00389.
    PubMed     Text format    


  56. BAI H, Yuan F, Wang H, Chen J, et al
    The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
    Int J Gynaecol Obstet. 2015 Jun 3. pii: S0020-7292(15)00289.
    PubMed     Text format     Abstract available


    May 2015
  57. TAY K, Tay SK, Tesalona KC, Rashid NM, et al
    Factors affecting the uptake of cervical cancer screening among nurses in Singapore.
    Int J Gynaecol Obstet. 2015 May 23. pii: S0020-7292(15)00280.
    PubMed     Text format     Abstract available


  58. THULASEEDHARAN JV, Malila N, Esmy PO, Muwonge R, et al
    Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural South India.
    Int J Gynaecol Obstet. 2015;129:104-8.
    PubMed     Text format     Abstract available


    March 2015
  59. HERACLIO SA, Schettini J, Oliveira ML, Souza AS, et al
    High-resolution anoscopy in women with cervical neoplasia.
    Int J Gynaecol Obstet. 2015;128:216-9.
    PubMed     Text format     Abstract available


    October 2014
  60. KYRGIOU M, Valasoulis G, Stasinou SM, Founta C, et al
    Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes.
    Int J Gynaecol Obstet. 2014 Oct 2. pii: S0020-7292(14)00480.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: